Val Gebski
0000-0001-8748-1844
NHMRC Clinical Trials Centre
3 papers found
Refreshing results…
Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trial
Recurrent time‐to‐event models with ordinal outcomes
Missing publications? Search for publications with a matching author name.